These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Antiangiogenic drugs synergize with a membrane macrophage colony-stimulating factor-based tumor vaccine to therapeutically treat rats with an established malignant intracranial glioma. Jeffes EW; Zhang JG; Hoa N; Petkar A; Delgado C; Chong S; Obenaus A; Sanchez R; Khalaghizadeh S; Khomenko T; Knight BA; Alipanah R; Nguyen TV; Shah C; Vohra S; Zhuang JL; Liu J; Wepsic HT; Jadus MR J Immunol; 2005 Mar; 174(5):2533-43. PubMed ID: 15728459 [TBL] [Abstract][Full Text] [Related]
28. An experimental study of dendritic cells-mediated immunotherapy against intracranial gliomas in rats. Zhu X; Lu C; Xiao B; Qiao J; Sun Y J Neurooncol; 2005 Aug; 74(1):9-17. PubMed ID: 16078102 [TBL] [Abstract][Full Text] [Related]
29. Immunoregulatory role in gamma interferon production by a T cell growth factor-dependent experimental malignant glioma-specific cytotoxic T lymphocyte clone. Yamasaki T; Handa H; Yamashita J; Watanabe Y; Taguchi M; Kuwata S; Namba Y; Hanaoka M J Neurosurg; 1985 Nov; 63(5):763-70. PubMed ID: 3932609 [TBL] [Abstract][Full Text] [Related]
31. [Local hyperthermia therapy of malignant brain tumor using radiofrequency. Effects on subcutaneously transplanted experimental brain tumor]. Kim T; Tanaka R; Suzuki Y; Sekiguchi K; Yamada N; Saito Y Neurol Med Chir (Tokyo); 1982 Feb; 22(2):103-10. PubMed ID: 6178045 [No Abstract] [Full Text] [Related]
32. Glioma immunotherapy by IL-21 gene-modified cells or by recombinant IL-21 involves antibody responses. Daga A; Orengo AM; Gangemi RM; Marubbi D; Perera M; Comes A; Ferrini S; Corte G Int J Cancer; 2007 Oct; 121(8):1756-63. PubMed ID: 17582604 [TBL] [Abstract][Full Text] [Related]
33. Immunogene therapy as a treatment for malignant brain tumors in young mice. Glick RP; Lichtor T; Lin H; Tarlock K; Cohen EP J Neurosurg; 2006 Jul; 105(1 Suppl):65-70. PubMed ID: 16871873 [TBL] [Abstract][Full Text] [Related]
34. [Effects of TCGF (T-cell growth factor) on experimental malignant glioma-specific killer T-cell]. Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M No Shinkei Geka; 1984 Feb; 12(2):141-50. PubMed ID: 6609319 [TBL] [Abstract][Full Text] [Related]
35. Augmentation versus inhibition: effects of conjunctional OX-40 receptor monoclonal antibody and IL-2 treatment on adoptive immunotherapy of advanced tumor. Kjaergaard J; Peng L; Cohen PA; Drazba JA; Weinberg AD; Shu S J Immunol; 2001 Dec; 167(11):6669-77. PubMed ID: 11714839 [TBL] [Abstract][Full Text] [Related]
36. Rat mitogen-stimulated lymphokine-activated T killer cells: production and effects on C6 glioma cells in vitro and in vivo in the brain of Wistar rats. Carson WE; Jakowatz JG; Yamamoto R; Fitzgerald T; Gupta S; Vayuvegula B; Lucci JA; Beckman MT; Dulkanchainun S; Granger GA J Immunother (1991); 1991 Apr; 10(2):131-40. PubMed ID: 2043593 [TBL] [Abstract][Full Text] [Related]
37. Intracerebral versus subcutaneous immunization with allogeneic fibroblasts genetically engineered to secrete interleukin-2 in the treatment of central nervous system glioma and melanoma. Glick RP; Lichtor T; Mogharbel A; Taylor CA; Cohen EP Neurosurgery; 1997 Oct; 41(4):898-906; discussion 906-7. PubMed ID: 9316052 [TBL] [Abstract][Full Text] [Related]
38. [Experimental studies on the treatment of recurrent gliomas]. Yamada M; Shimizu K; Okamoto Y; Miyao Y; Matsui Y; Tsuda N; Mogami H Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1890-5. PubMed ID: 3496051 [TBL] [Abstract][Full Text] [Related]
39. Intratumoral COX-2 inhibition enhances GM-CSF immunotherapy against established mouse GL261 brain tumors. Eberstål S; Sandén E; Fritzell S; Darabi A; Visse E; Siesjö P Int J Cancer; 2014 Jun; 134(11):2748-53. PubMed ID: 24243648 [TBL] [Abstract][Full Text] [Related]
40. [Antineoplastic effect of Hu-IFN-beta and other anticancer drugs on malignant brain tumors in athymic nude mice]. Nakamura O; Nomura K; Maruo K; Ueyama Y; Takakura K No Shinkei Geka; 1985 May; 13(5):503-8. PubMed ID: 2410803 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]